You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!Submit Review
Potent and selective PAR2 receptor agonist (pD2 = 7.0). Causes a dose-dependent relaxation of murine femoral arteries.
(Modifications: Leu-1 = 2-Furoyl-Leu, X = Orn & C-terminal amide)
|Storage||Store at -20°C|
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
|Solubility||Soluble to 1 mg/ml in water|
References are publications that support the biological activity of the product.
McGuire et al (2004) 2-Furoyl-LIGRLO-amide: a potent and selective proteinase-activated receptor 2 agonist. J.Pharmacol.Exp.Ther. 309 1124 PMID: 14976230
Alshurafa et al (2004) A protease activated receptor-2 (PAR-2) activating peptide, tc-LIGRLO-NH2, induces protease release from mast cells: role in TNF degradation. BMC Pharmacol. 4 12 PMID: 15265236
Olianas et al (2007) Proteinase-activated receptors 1 and 2 in rat olfactory system: layer-specific regulation of multiple signaling pathways in the main olfactory bulb and induction of neurite retraction in olfactory sensory neurons. Neuroscience 146 1289 PMID: 17434682
If you know of a relevant reference for 2-Furoyl-LIGRLO-amide, please let us know.
View Related Products by Target
View Related Products by Product Action
Keywords: 2-Furoyl-LIGRLO-amide, 2-Furoyl-LIGRLO-amide supplier, Potent, selective, PAR2, agonists, Receptors, Protease-Activated, proteinase-activated, 3015, Tocris Bioscience
3 Citations for 2-Furoyl-LIGRLO-amide
Citations are publications that use Tocris products. Selected citations for 2-Furoyl-LIGRLO-amide include:
Pal et al (2013) Divergent β-arrestin-dependent signaling events are dependent upon sequences within G-protein-coupled receptor C termini. J Biol Chem 288 3265 PMID: 23235155
Oe et al (2019) Protease-activated receptor 2 protects against VEGF inhibitor-induced glomerular endothelial and podocyte injury. Sci.Rep. 9 2986 PMID: 30814628
Sales et al (2015) Non-hematopoietic PAR-2 is essential for matriptase-driven pre-malignant progression and potentiation of ras-mediated squamous cell carcinogenesis. Am J Physiol Cell Physiol 34 346 PMID: 24469043
Do you know of a great paper that uses 2-Furoyl-LIGRLO-amide from Tocris? Please let us know.
Reviews for 2-Furoyl-LIGRLO-amide
Average Rating: 5 (Based on 1 Review.)
Have you used 2-Furoyl-LIGRLO-amide?
Submit a review and receive an Amazon gift card.
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
ex-vivo mouse colonic tissue
Used this compound on an ex-vivo experiment. Tissue: Mouse colon.2F caused massive PAR2 receptor internalization in the colonic mucosa.Very easy to dissolve, great and potent PAR2 Agonist.
Literature in this Area
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.